{"result": {"id": "chatcmpl-177", "choices": [{"finish_reason": "stop", "index": 0, "logprobs": null, "message": {"content": "The **CD31** antibody is an immunofluorescence staining target used to detect and visualize blood vessels. It is also employed in ex vivo experiments, specifically for studying angiogenesis.  This protein plays a crucial role in angiogenesis, the process of forming new blood vessels. CD31 is a marker for blood vessels and has been utilized in studies focusing on corneal tissue. \n", "refusal": null, "role": "assistant", "annotations": null, "audio": null, "function_call": null, "tool_calls": null}}], "created": 1743328199, "model": "gemma2:2b", "object": "chat.completion", "service_tier": null, "system_fingerprint": "fp_ollama", "usage": {"completion_tokens": 76, "prompt_tokens": 188, "total_tokens": 264, "completion_tokens_details": null, "prompt_tokens_details": null}}, "input": {"messages": [{"content": "\nYou are a helpful assistant responsible for generating a comprehensive summary of the data provided below.\nGiven one or two entities, and a list of descriptions, all related to the same entity or group of entities.\nPlease concatenate all of these into a single, comprehensive description. Make sure to include information collected from all the descriptions.\nIf the provided descriptions are contradictory, please resolve the contradictions and provide a single, coherent summary.\nMake sure it is written in third person, and include the entity names so we have the full context.\n\n#######\n-Data-\nEntities: \"CD31\"\nDescription List: [\"Antibody used for staining CD31 in ex vivo experiments\", \"Antibody used to detect angiogenesis\", \"Immunofluorescence staining target\", \"Marker for blood vessels\", \"Protein involved in angiogenesis\", \"Protein used in a study of corneal tissue\"]\n#######\nOutput:\n", "role": "user"}], "parameters": {"model": "gemma2:2b", "frequency_penalty": 0.0, "max_tokens": 500, "n": 1, "presence_penalty": 0.0, "temperature": 0.0, "top_p": 1.0}}, "key": "chat_summarize_5eb1b2e3162e5c1c196f0b9a33def924619dc43c5cbfb832406c86ba85d962ea_v2"}